Acompanhe as Notícias da Recifes

Researchers at Moffitt Cancer Center have developed three mathematical biomarkers that may help physicians personalize adaptive therapy for prostate cancer by predicting treatment outcomes early in treatment. The biomarkers are specialized mathematical measures calculated from ro

The cost-effectiveness of the immunotherapy drug pembrolizumab for patients with locally advanced head and neck squamous cell carcinoma may depend on biomarker results, according to a new study.

The first results from the multicenter FUSOMAP project, published in ESMO Open and led by VHIO's Molecular Oncology Group, show that the presence of intratumoral Fusobacterium in surgical tumor samples identifies a clinically more aggressive subtype of colorectal cancer (CRC), ch